Ketamine Improved Chronic Pain for Patients with Cancer Following Surgery
Drug Topics
OCTOBER 31, 2024
Researchers conducted a systematic review of randomized trials to determine the efficacy of ketamine for patients with cancer.
Thu.Oct 31, 2024
492 
STAT+: Teva fined $503 million for disparaging a rival and using patents to thwart competition
STAT
OCTOBER 31, 2024
Teva Pharmaceutical, the world’s largest generic drugmaker, was fined $503 million by European antitrust regulators for delaying competition to a blockbuster multiple sclerosis medicine. The European Commission found the company had artificially extended the patent protection of Copaxone and systematically spread misleading information about a rival product.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
How to Turn Patient Visits into Clinical Encounters in the Pharmacy | NCPA 2024
Drug Topics
OCTOBER 31, 2024
Presenters at the National Community Pharmacists Association 2024 Annual Convention and Expo discussed workflow and the future of pharmacy as a patient destination.
STAT+: Two generic drugmakers pay $49 million to settle price-fixing charges
STAT
OCTOBER 31, 2024
Two generic drugmakers, Apotex and Heritage Pharmaceuticals, have agreed to pay a combined $49 million to settle allegations they fixed prices on numerous medicines, the first such agreements since state attorneys general began probing price-fixing in the generics industry a decade ago. In 2016, a number of states filed what eventually became the first in a trio of lawsuits against many of the largest generic companies for allegedly coordinating efforts to fix and maintain prices for dozens of m
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
Drug Topics
OCTOBER 31, 2024
Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
FDA removes Novo's Wegovy from shortage list, marking end of semaglutide supply rout in US
Fierce Pharma
OCTOBER 31, 2024
Less than a month after the FDA removed Eli Lilly’s tirzepatide from its shortage list, the agency has done the same for Novo Nordisk’s rival GLP-1 semaglutide, potentially signaling the end of a d | The FDA this week revised its shortage list to note that the.25 mg starter dose of Novo’s semaglutide-based obesity med Wegovy is now available in the U.S.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Independent Pharmacies Should Expand Their Vaccination Programs | NCPA 2024
Drug Topics
OCTOBER 31, 2024
A conversation with David Ha, PharmD, BCIDP, at the National Community Pharmacists Association 2024 Annual Convention and Expo.
STAT+: These 10 scientists are leading a new generation of gene editors developing CRISPR medicines
STAT
OCTOBER 31, 2024
Barely 12 years after the publication of the first papers unveiling CRISPR-Cas9, a powerful enzyme for editing DNA, sickle cell patients are now receiving the first approved CRISPR-based medicine, Casgevy. Hundreds of patients with other inherited diseases, cancers, and chronic bacterial and viral infections are enrolled in clinical trials testing other CRISPR treatments.
The Essential Tech Stack for Pharmacy Owners
Drug Topics
OCTOBER 31, 2024
Lisa Faast, PharmD, Founder and CEO of Diversify Rx, discussed how technology is used to innovate within the pharmacy.
Pharmacists Can Directly Improve Health Literacy
Pharmacy Times
OCTOBER 31, 2024
Incorporating the teach-back method and providing patient handouts expand health knowledge.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Patient Engagement and the Future of Community Pharmacy as a Health Care Destination
Drug Topics
OCTOBER 31, 2024
Ian Stone, Senior Vice President at Mesmerize, discussed the essential aspects of a community pharmacy and how his company can help independent owners excel in the future.
Life sciences response to 2024 Autumn Budget
European Pharmaceutical Review
OCTOBER 31, 2024
Announcement of the UK Government’s 2024 Autumn Budget on 30 October marks the first Labour budget in 14 years. It pledges to benefit key industry sectors across life sciences including R&D, innovation, manufacturing and medicine. Commitment to manufacturing the £520 million life sciences innovative manufacturing fund is very welcome, and will be crucial in helping to capture high-productivity investment” The Association of the British Pharmaceutical Industry (ABPI) backed the proposed
GoodRx, Opill Partner on OTC Delivery Program to Address Gaps in Access
Drug Topics
OCTOBER 31, 2024
GoodRx’s new e-commerce service further expands access to Opill by allowing consumers to order the birth control directly to their homes without a prescription.
STAT+: Small mid-stage trial suggests targeted magnetic pulses to brain could slow Alzheimer’s
STAT
OCTOBER 31, 2024
After spending decades fixated on a single hypothesis, Alzheimer’s researchers are increasingly searching for new ways to combat the devastating neurologic disease. One such approach — precisely targeting the brain with magnetic pulses — got a boost when mid-stage trial data was presented Thursday. Scientists reported that patients with mild or moderate Alzheimer’s who received the therapy, known as transcranial magnetic stimulation (TMS), experienced a 44% slowing in
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Weathering the Storm: Medication Preparedness in Hurricane Season
Drug Topics
OCTOBER 31, 2024
Hurricane season brings extreme weather and health care disruptions, emphasizing the importance of medication preparedness for patients and pharmacists.
NCODA Fall Summit Recap: Key Sessions and Expert Interviews From the 2024 Meeting
Pharmacy Times
OCTOBER 31, 2024
The 2024 NCODA International Fall Summit took place in Orlando, Florida, from October 23 to October 25.
UnitedHealth Group, University of Minnesota partner to launch course on value-based care
Fierce Healthcare
OCTOBER 31, 2024
Making true progress toward value-based care requires buy-in and understanding from physicians — and for them to be willing to find common ground with insurers for collaborating. | UnitedHealth Group partnered with the University of Minnesota's medical school to launch a four-week elective course that exposes fourth-year medical students to value-based care and has them working in person with Optum clinicians.
Smoking Cessation Within 6 Months of Cancer Diagnosis Boosts Survival Rates for Patients With Lung Cancer
Pharmacy Times
OCTOBER 31, 2024
Following lung cancer diagnosis, adjusting lifestyle habits can improve treatment responses.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Optum Rx rolling out new initiatives aimed at supporting independent pharmacists
Fierce Healthcare
OCTOBER 31, 2024
Optum Rx is rolling out a slate of new programs that seek to support independent pharmacies in managing costs and more complex patient needs. | Optum Rx is rolling out a slate of new programs that seek to support independent pharmacies in managing costs and more complex patient needs.
Community Pharmacies in Crisis: Navigating the Challenges and Closures
Pharmaceutical Commerce
OCTOBER 31, 2024
With today's pharmacy landscape shaken by unprecedented and wider disruption to healthcare support and delivery, community and independent entities strive to remain an integral cog in the mix.
Novo Nordisk Foundation Announces Start Up of Denmark’s First AI Supercomputer Geared to Accelerate Drug Discovery Innovation
BioPharm
OCTOBER 31, 2024
The Novo Nordisk Foundation has committed DKK 600 million (US$87.4 million) towards the initial costs of the center housing the new supercomputer, which has the potential to accelerate drug discovery innovation.
Why language training is crucial for healthcare teams
pharmaphorum
OCTOBER 31, 2024
Effective language training for healthcare teams within the NHS is crucial for providing quality care and communication with diverse patient populations. Learn why it is essential for healthcare professionals.
Cigna posts $739M in Q3 profit despite taking a $1B hit from VillageMD investment
Fierce Healthcare
OCTOBER 31, 2024
The Cigna Group reported $739 million in profit for the third quarter, a figure that accounts for a $1 billion after-tax investment loss tied to VillageMD. | The Cigna Group reported $739 million in profit for the third quarter, a figure that accounts for a $1 billion after-tax investment loss tied to VillageMD.
Compass points to job cuts as it defers trial readouts
pharmaphorum
OCTOBER 31, 2024
Compass Pathways will cut its headcount by 30% as it defers phase 3 readouts for its psychedelic therapy for treatment-resistant depression.
Standout breast cancer trial outcomes for Roche small molecule therapy
European Pharmaceutical Review
OCTOBER 31, 2024
New Phase III analysis reports that an Itovebi TM (inavolisib)-based combination treatment more than doubled progression-free survival in advanced breast cancer patients. The treatment lowered disease risk worsening or death by 57 percent, according to the analysis from Roche’s Phase III INAVO120 study. This was in comparison to palbociclib and fulvestrant only.
Teva fined €462.6m for antitrust delay to MS drug rivals
pharmaphorum
OCTOBER 31, 2024
The European Commission has delivered a hefty fine to Teva for abusing a dominant position in multiple sclerosis by artificially extending the patent protection for former blockbuster Copaxone.
Lung Cancer Screenings Can Save Lives, Yet Uptake Remains Low
Pharmacy Times
OCTOBER 31, 2024
Further efforts may be required to urge eligible members of the public to get screened for lung cancer.
Higher MA enrollment linked to lower Medicare spending: report
Fierce Healthcare
OCTOBER 31, 2024
Medicare Advantage’s popularity is associated with lower total Medicare spending, a new report from Elevance Health finds. | Elevance Health researchers might have an explanation for lower-than-expected Medicare spending: the proliferation of Medicare Advantage plans.
Alpha-9's $175m third-round heads latest biotech financings
pharmaphorum
OCTOBER 31, 2024
Our latest round-up of financings in the biotech sector features Alpha-9 Oncology, Axonis, Kivu Bio, SynOx, Agomab, and Blue Earth Therapeutics.
Advanced Therapies Redefine Survival for Patients With Breast Cancer
Pharmacy Times
OCTOBER 31, 2024
Targeted therapies, CDK4/6 inhibitors, and precision medicine are improving outcomes for patients with high-risk and metastatic disease.
Regeneron's Eylea HD makes progress but doesn't dent the momentum of Roche's Vabysmo
Fierce Pharma
OCTOBER 31, 2024
With U.S. | With U.S. sales of $392 million in the third quarter, Regeneron’s high-dose version of Eylea is closing in on blockbuster sales in its first full year on the market. The bad news for the company, however, is that while sales from Eylea HD increased by 29% sequentially, this didn't translate to a similar bump in overall U.S. revenue for the Eylea family of eye medications.
The Needs of One Are the Needs of Many: Everyone Counts in Health Care
Pharmacy Times
OCTOBER 31, 2024
A patient with BPDCN finds her champion.
STAT+: Pharmalittle: We’re reading about the FDA listing Novo drugs as ‘available,’ pharma layoffs, and more
STAT
OCTOBER 31, 2024
Rise and shine, everyone, another busy day is on the way. We can tell by the sudden presence of little ghouls and goblins walking past. No doubt, they are in search of the great pumpkin. We wish them luck, because you never know what you may find on that elusive quest. Of course, this calls for a cup of stimulation, and we are opening a new package of pecan pie for the occasion.
Let's personalize your content